Alkem Laboratories Limited has informed the Exchange about an Update regarding the acquisition of 100% stake of Bombay Ortho Industries Private Limited, a company incorporated in India, by M/s. Alkem Medtech Private Limited, a wholly owned subsidiary of the Company in India.
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has shared an update on the acquisition of a 100% stake in Bombay Ortho Industries Private Limited, an India-incorporated company likely operating in the orthopedic/medical devices space. The acquisition is being executed through M/s. Alkem Medtech Private Limited, which is a wholly owned subsidiary of Alkem Laboratories in India. This is an update to a previously disclosed transaction, suggesting the deal is progressing through its completion stages. The move strengthens Alkem's presence in the orthopedic segment via its dedicated medtech arm.
This acquisition deepens Alkem's footprint in the medical devices and orthopedic space, potentially expanding its product portfolio and revenue base over the medium term. For shareholders, it signals a strategic push into high-growth adjacencies beyond core pharma, though the financial impact will depend on the deal value and integration outcomes.